DelveInsight's 'Skin Burns- Market Insights, Epidemiology and Market Forecast-2028' report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Skin Burns in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Skin Burns from 2017 to 2028 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
Burn is a thermal injury caused by biological, chemical, electrical and physical agents with local and systemic repercussions, these are the most severe form of trauma that has afflicted humanity since time immemorial and that over the years and the scientific revolution has improved the results in its treatment.
Burn is a thermal injury caused by biological, chemical, electrical and physical agents with local and systemic repercussions, these are the most severe form of trauma that has afflicted humanity since time immemorial and that over the years and the scientific revolution has improved the results in its treatment.
The DelveInsight Skin Burns market report gives a thorough understanding of the Skin Burns by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Skin Burns in the US, Europe, and Japan.
The Skin Burns epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed and treatable patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report is segmented by diagnosed incident population, hospitalized-visit incident population of Skin Burns, gender-specific diagnosed incident population and severity-specific diagnosed incident population and cause- specific diagnosed incident population of Skin Burns.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the incident population of Skin Burns was estimated to be 16,800 [7MM] in 2018. United States accounts for the highest skin-burn cases, followed by EU5 (Germany, France, Italy, Spain and UK) and Japan. Among the EU5 countries UK had the highest incident patient population of Skin Burns, followed France.
This segment of the Skin Burns report encloses the detailed analysis of marketed drugs and late stage (Phase-III) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
The treatment regimen of skin burns is mainly classified according to the intensity of the impact and severity of the burn. Moisturizers, over the counter analgesics and /or anti-inflammatory agents, hydration and topical treatments (such as silver releasing agents). Although silver has been used in the form of salts such as Silver nitrate and silver sulfadiazine (Silvadene; King Pharmaceuticals, Inc.) since the past forty years, the available delivery systems often in the form of a salt have been limiting factors to successful biologic use of this noble metal in burn wound care. Xenografts introduce exogenous collagen into the wound, which aids dermal regeneration. Some of the commonly used products include Matriderm (Suwelack Skin and Health Care Ag) and Oasis (Healthpoint, Fort Worth). Second degree burns are treated with topical medications in superficial cases. However, for deep burn cases TransCyte (Advanced BioHealing, Inc.) is a dressing that is in use. The primary reason being that they impair fibroblast and epithelial proliferation, which in turn delays healing.
Detailed chapters for all of these drugs along with other marketed therapies have been covered in the report.
The Skin Burns market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the global market of Skin Burns was estimated to be USD 1452.96 million in 2018. The United States accounts for the largest market size of Skin Burns, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain), and Japan. The most promising candidate which was recently approved by the US FDA is Avita Medical's RECELL System (RECELL Autologous Cell Harvesting Device). It is the first spray-on skin product to win approval for the U.S. market and is expected to transform the way burns are treated worldwide.
The dynamics of Skin Burns market is anticipated to change in the coming years owing to the expected launch of emerging therapies during the forecasted period 2019-2028. Key players are working robustly on new therapies with novel mechanism of action, including StrataGraft (Mallinckrodt), CellMist System (RenovaCare).
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Expected launch of potential therapies will lead to an increase in the market size of Skin Burns in the coming years.
• Patient Population
• Therapeutic Approaches
• Pipeline Analysis
• Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies
• 10 Year Forecast
• 7MM Coverage
• Epidemiology Segmentation
• Drugs Uptake
• Highly Analyzed Market
• Key Cross Competition
• Current Treatment Practices
• Unmet Needs
• Detailed Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers
• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Skin Burns market.
• Organize sales and marketing efforts by identifying the best opportunities for Skin Burns market.
• To understand the future market competition in the Skin Burns market.
1 Key Insights
2 Skin Burns Market Overview at a Glance
2.1 Market Share (%) Distribution of Skin Burns in 2017
2.2 Market Share (%) Distribution of Skin Burns in 2028
3 Disease Background and Overview
3.1 Introduction
3.2 Classification
3.3 Signs and Symptoms
3.4 Pathophysiology
3.5 Mechanism involved in Burn-Induced Microvascular Inflammation
3.6 Diagnosis
3.6.1 American Burn Association Burn Unit Referral Criteria
3.7 Diagnostic Approach to Skin Burns
3.7.1 Japanese Dermatological Association: Wound/Burn Guidelines
4 Epidemiology and Patient Population
4.1 Key Findings
5 7MM Total Prevalent Patient Population of Skin Burns
6 Country Wise-Epidemiology of Skin Burns
7 United States
7.1 Assumptions and Rationale
7.2 Total Incident Cases of Skin Burns in the United States
7.3 Total Hospitalized Visit Cases of Skin Burns in the United States
7.4 Incident Cases of Skin Burns by Severity in the United States
7.5 Incident Cases of Skin Burns by Cause in the United States
7.6 Incident Cases of Skin Burns by Gender in the United States
8 EU5
8.1 Assumptions and Rationale
9 Germany
9.1 Total Incident Cases of Skin Burns in Germany
9.2 Total Hospitalized Visit Cases of Skin Burns in Germany
9.3 Incident Cases of Skin Burns by Severity in Germany
9.4 Incident Cases of Skin Burns by Cause in Germany
9.5 Incident Cases of Skin Burns by Gender in Germany
10 France
10.1 Total Incident Cases of Skin Burns in France
10.2 Total Hospitalized Visit Cases of Skin Burns in France
10.3 Incident Cases of Skin Burns by Severity in France
10.4 Incident Cases of Skin Burns by Cause in France
10.5 Incident Cases of Skin Burns by Gender in France
11 Italy
11.1 Total Incident Cases of Skin Burns in Italy
11.2 Total Hospitalized Visit Cases of Skin Burns in Italy
11.3 Incident Cases of Skin Burns by Severity in Italy
11.4 Incident Cases of Skin Burns by Cause in Italy
11.5 Incident Cases of Skin Burns by Gender in Italy
12 Spain
12.1 Total Incident Cases of Skin Burns in Spain
12.2 Total Hospitalized Visit Cases of Skin Burns in Spain
12.3 Incident Cases of Skin Burns by Severity in Spain
12.4 Incident Cases of Skin Burns by Cause in Spain
12.5 Incident Cases of Skin Burns by Gender in Spain
13 United Kingdom
13.1 Total Incident Cases of Skin Burns in the United Kingdom
13.2 Total Hospitalized Visit Cases of Skin Burns in the United Kingdom
13.3 Incident Cases of Skin Burns by Severity in the United Kingdom
13.4 Incident Cases of Skin Burns by Cause in the United Kingdom
13.5 Incident Cases of Skin Burns by Gender in the United Kingdom
14 Japan
14.1 Assumptions and Rationale
14.2 Total Incident Cases of Skin Burns in Japan
14.3 Total Hospitalized Visit Cases of Skin Burns in Japan
14.4 Incident Cases of Skin Burns by Severity in Japan
14.5 Incident Cases of Skin Burns by Cause in Japan
14.6 Incident Cases of Skin Burns by Gender in Japan
15 Treatment of Skin Burns
15.1.1 Emergency Management
15.1.2 Specific Treatment
15.2 WHO Guidelines for Management of Burns
15.2.1 Burn Management in Adults
15.2.2 Burn Management in Children
15.2.3 Depth of burn
15.2.4 Wound Care
15.3 NHS Guidelines on the Initial Assessment & Management of Burn-Injured Patients
15.3.1 Assessment & Management of Imminently Life-Threatening Problems
15.3.2 Assessment of the Burn Wound
15.3.3 Intravenous Fluid Resuscitation
15.3.4 Smoke Inhalation Injury
15.3.5 Burn Wound Management
15.3.6 Analgesia
15.3.7 Referral to a Specialised Burns Service
15.3.8 Transfer to a Specialised Burns Service
15.4 Japanese Dermatological Association: Wound/Burn Guidelines
15.5 Therapeutic Algorithm for Local Burn Wound
16 Unmet Needs
17 Marketed Therapies
17.1 Topical Treatments: Antimicrobials, Antibiotics, and others
17.2 Silvadene: Pfizer
17.2.1 Drug Description
17.2.2 Regulatory Milestones
17.2.3 Other Developmental Activities
17.3 Skin Substitutes
17.3.1 Temporary Skin Substitutes
17.3.2 Permanent Skin Substitutes
17.4 “Spray-On Skin” Therapy
17.5 Recell: Avita Medical
17.5.1 Product Description
17.5.2 Regulatory Milestones
18 Emerging Therapies
18.1 Key cross competition- Emerging Therapies
18.2 StrataGraft: Mallinckrodt
18.2.1 Product Description
18.2.2 Other Development Activities
18.2.3 Clinical Development
18.2.4 Safety and Efficacy
18.2.5 Product Profile
18.3 SkinGun (CellMist System): RenovaCare
18.3.1 Product Description
18.3.2 Other Development Activities
18.3.3 Clinical Development
18.3.4 Safety and Efficacy
18.3.5 Product Profile
19 Skin Burns: 7 Major Market Analysis
19.1 Key Findings
19.2 Total Market Size of Skin Burns in 7MM
19.1 7 MM Size of Skin Burns by Therapies
20 Market Outlook by Country
21 The United States: Market Outlook
21.1 United States Market Size
21.1.1 Total Market size of Skin Burns in the United States
21.1.2 Skin Burns Market By therapies
22 EU-5 Countries: Market Outlook
22.1 Germany Market Size
22.1.1 Total Market size of Skin Burns in Germany
22.1.2 Skin Burns Market By therapies
22.2 France Market Size
22.2.1 Total Market size of Skin Burns in France
22.2.2 Skin Burns Market By therapies
22.3 Italy Market Size
22.3.1 Total Market size of Skin Burns in Italy
22.3.2 Skin Burns Market By therapies
22.4 Spain Market Size
22.4.1 Total Market size of Skin Burns in Spain
22.4.2 Skin Burns Market By therapies
22.5 The United Kingdom Market Size
22.5.1 Total Market size of Skin Burns in the United Kingdom
22.5.2 Skin Burns Market By therapies
23 Japan: Market Outlook
23.1 Japan: Market Size
23.1.1 Total Market size of Skin Burns in Japan
23.1.2 Skin Burns Market By therapies
24 Market Drivers
25 Market Barriers
26 Appendix
26.1 Report Methodology
27 DelveInsight Capabilities
28 Disclaimer
29 About DelveInsight
Table 1: Classification by Etiology of burns
Table 2: Clinical characteristics according to the degree of depth
Table 3: Criteria of reference to a center specialized in burns
Table 4: Rule of Nines for Establishing Extent of Body Surface Burned
Table 5: Evidence Levels
Table 6: Recommendation Levels
Table 7: Method for the estimation of the depth based on clinical findings
Table 8: Prevalent Patient Population of Skin Burns in 7MM (2017-2028)
Table 9: Total Incident Cases of Skin Burns in the United States (2017-2028)
Table 10: Total Hospitalized Visit Cases of Skin Burns in the United States (2017-2028)
Table 11: Incident Cases of Skin Burns by Severity in the United States (2017-2028)
Table 12: Incident Cases of Skin Burns by Cause in the United States (2017-2028)
Table 13: Incident Cases of Skin Burns by Gender in the United States (2017-2028)
Table 14: Total Incident Cases of Skin Burns in Germany (2017-2028)
Table 15: Total Hospitalized Visit Cases of Skin Burns in Germany (2017-2028)
Table 16: Incident Cases of Skin Burns by Severity in Germany (2017-2028)
Table 17: Incident Cases of Skin Burns by Cause in Germany (2017-2028)
Table 18: Incident Cases of Skin Burns by Gender in Germany (2017-2028)
Table 19: Total Incident Cases of Skin Burns in France (2017-2028)
Table 20: Total Hospitalized Visit Cases of Skin Burns in France (2017-2028)
Table 21: Incident Cases of Skin Burns by Severity in France (2017-2028)
Table 22: Incident Cases of Skin Burns by Cause in France (2017-2028)
Table 23: Incident Cases of Skin Burns by Gender in France (2017-2028)
Table 24: Total Incident Cases of Skin Burns in Italy (2017-2028)
Table 25: Total Hospitalized Visit Cases of Skin Burns in Italy (2017-2028)
Table 26: Incident Cases of Skin Burns by Severity in Italy (2017-2028)
Table 27: Incident Cases of Skin Burns by Cause in Italy (2017-2028)
Table 28: Incident Cases of Skin Burns by Gender in Italy (2017-2028)
Table 29: Total Incident Cases of Skin Burns in Spain (2017-2028)
Table 30: Total Hospitalized Visit Cases of Skin Burns in Spain (2017-2028)
Table 31: Incident Cases of Skin Burns by Severity in Spain (2017-2028)
Table 32: Total Incident Cases of Skin Burns in the United Kingdom (2017-2028)
Table 33: Total Hospitalized Visit Cases of Skin Burns in the United Kingdom (2017-2028)
Table 34: Incident Cases of Skin Burns by Severity in the United Kingdom (2017-2028)
Table 35: Incident Cases of Skin Burns by Cause in the United Kingdom (2017-2028)
Table 36: Incident Cases of Skin Burns by Gender in the United Kingdom (2017-2028)
Table 37: Total Incident Cases of Skin Burns in Japan (2017-2028)
Table 38: Total Hospitalized Visit Cases of Skin Burns in Japan (2017-2028)
Table 39: Incident Cases of Skin Burns by Severity in Japan (2017-2028)
Table 40: Incident Cases of Skin Burns by Cause in Japan (2017-2028)
Table 41: Incident Cases of Skin Burns by Gender in Japan (2017-2028)
Table 42: Depth of Burn Characteristics
Table 43: At the Scene of Injury: Approach
Table 44: Transfer to Hospital: Treatment Approach
Table 45: Assessment and Management of Imminently Life-Threatening Problems
Table 46: Assessment and Management of Imminently Life-Threatening Problems
Table 47: List of few Topical Agents
Table 48: List of Temporary Skin Substitutes
Table 49: List of Permanent Skin Substitutes
Table 50: Key cross competition - Emerging Therapies
Table 51: Lucerastat, Clinical Trial Description, 2018
Table 52: 7 Major Market Size of Skin Burns in USD Million (2017-2028)
Table 53: 7 Major Market Skin Burns Market Size by Therapies in USD Million (2017-2028)
Table 54: Total Market Size of Skin Burns in the United States, USD Millions (2017-2028)
Table 55: United States Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Table 56: Total Market Size of Skin Burns in Germany , USD Millions (2017-2028)
Table 57: Germany Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Table 58: Total Market Size of Skin Burns in France, USD Millions (2017-2028)
Table 59: France Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Table 60: Total Market Size of Skin Burns in Italy, USD Millions (2017-2028)
Table 61: Italy Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Table 62: Total Market Size of Skin Burns in Spain, USD Millions (2017-2028)
Table 63: Spain Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Table 64: Total Market Size of Skin Burns in the United Kingdom, USD Millions (2017-2028)
Table 65: United Kingdom Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Table 66: Total Market Size of Skin Burns in Japan , USD Millions (2017-2028)
Table 67: Japan Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 1: Signs and Symptoms of Skin Burns
Figure 2: Anatomy of Normal Skin
Figure 3: Jackson's burn wound model
Figure 4: Prevalent Patient Population of Skin Burns in 7MM (2017-2028)
Figure 5: Total Incident Cases of Skin Burns in the United States (2017-2028)
Figure 6: Total Hospitalized Visit Cases of Skin Burns in the United States (2017-2028)
Figure 7: Incident Cases of Skin Burns by Severity in the United States (2017-2028)
Figure 8: Incident Cases of Skin Burns by Cause in the United States (2017-2028)
Figure 9: Incident Cases of Skin Burns by Gender in the United States (2017-2028)
Figure 10: Total Incident Cases of Skin Burns in Germany (2017-2028)
Figure 11: Total Hospitalized Visit Cases of Skin Burns in Germany (2017-2028)
Figure 12: Incident Cases of Skin Burns by Severity in Germany (2017-2028)
Figure 13: Incident Cases of Skin Burns by Cause in Germany (2017-2028)
Figure 14: Incident Cases of Skin Burns by Gender in Germany (2017-2028)
Figure 15: Total Incident Cases of Skin Burns in France (2017-2028)
Figure 16: Total Hospitalized Visit Cases of Skin Burns in France (2017-2028)
Figure 17: Incident Cases of Skin Burns by Severity in France (2017-2028)
Figure 18: Incident Cases of Skin Burns by Cause in France (2017-2028)
Figure 19: Incident Cases of Skin Burns by Gender in France (2017-2028)
Figure 20: Total Incident Cases of Skin Burns in Italy 2017-2028)
Figure 21: Total Hospitalized Visit Cases of Skin Burns in Italy (2017-2028)
Figure 22: Incident Cases of Skin Burns by Severity in Italy (2017-2028)
Figure 23: Incident Cases of Skin Burns by Cause in Italy (2017-2028)
Figure 24: Incident Cases of Skin Burns by Gender in Italy (2017-2028)
Figure 25: Total Incident Cases of Skin Burns in Spain (2017-2028)
Figure 26: Total Hospitalized Visit Cases of Skin Burns in Spain (2017-2028)
Figure 27: Incident Cases of Skin Burns by Severity in Spain (2017-2028)
Figure 28: Incident Cases of Skin Burns by Cause in Spain (2017-2028)
Figure 29: Incident Cases of Skin Burns by Gender in Spain (2017-2028)
Figure 30: Total Incident Cases of Skin Burns in the United Kingdom (2017-2028)
Figure 31: Total Hospitalized Visit Cases of Skin Burns in the United Kingdom (2017-2028)
Figure 32: Incident Cases of Skin Burns by Severity in the United Kingdom (2017-2028)
Figure 33: Incident Cases of Skin Burns by Cause in the United Kingdom (2017-2028)
Figure 34: Incident Cases of Skin Burns by Gender in the United Kingdom (2017-2028)
Figure 35: Total Incident Cases of Skin Burns in Japan (2017-2028)
Figure 36: Total Hospitalized Visit Cases of Skin Burns in Japan (2017-2028)
Figure 37: Incident Cases of Skin Burns by Severity in Japan (2017-2028)
Figure 38: Incident Cases of Skin Burns by Cause in Japan (2017-2028)
Figure 39: Incident Cases of Skin Burns by Gender in Japan (2017-2028)
Figure 40: Paediatric and Adult Lund & Bowder Chart
Figure 41: Rule of Nines
Figure 42: Diagnostic and Treatment Algorithm for Burn Injury
Figure 43: Treatment Algorithm for Local Burn Wound
Figure 44: Unmet Needs of Skin Burns
Figure 45: 7 Major Market Size of Skin Burns in USD Million (2017-2028)
Figure 46: 7 Major Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 47: Total Market Size of Skin Burns in the United States, USD Millions (2017-2028)
Figure 48: United States Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 49: Total Market Size of Skin Burns in Germany, USD Millions (2017-2028)
Figure 50: Germany Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 51: Total Market Size of Skin Burns in France, USD Millions (2017-2028)
Figure 52: France Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 53: Total Market Size of Skin Burns in Italy, USD Millions (2017-2028)
Figure 54: Italy Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 55: Total Market Size of Skin Burns in Spain, USD Millions (2017-2028)
Figure 56: Spain Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 57: Total Market Size of Skin Burns in the United Kingdom, USD Millions (2017-2028)
Figure 58: United Kingdom Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 59: Total Market Size of Skin Burns in Japan, USD Millions (2017-2028)
Figure 60: Japan Market Size of Skin Burns by Therapies in USD Million (2017-2028)
Figure 61: Market Drivers
Figure 62: Market Barriers
